Section I: Antiepileptics (AEDs): Overview and Use in Neuropsychiatric Conditions

• Mechanisms of Action of Antiepileptic Drugs
• Antiepileptics in the Treatment of Epilepsy
• Antiepileptic Drugs in the Treatment of Neuropathic Pain
• The Antiepileptic Drugs and Migraine Prevention
• Antiepileptic Medications in the Treatment of Neuropsychiatric Symptoms Associated with Traumatic Brain Injury
• Antiepileptic Drugs in Intellectual Disability and/or Autism

Section II: AEDs in Psychiatric Disorders

• Treatment of Acute Manic and Mixed Episodes
• The Role of Antiepileptic Drugs in Long-Term Treatment of Bipolar Disorder
• Antiepileptic Drugs in the Treatment of Rapid-Cycling Bipolar Disorder and Bipolar Depression
• Role of Antiepileptic Drugs in the Treatment of Major Depressive Disorder
• Antiepileptics in the Treatment of Schizophrenia
• Antiepileptic Drugs in the Treatment of Anxiety Disorders: Role in Therapy
• Antiepileptics in the Treatment of Alcohol Withdrawal and Alcohol Use Relapse Prevention
• Antiepileptic Drugs in the Treatment of Drug Use Disorders
• Antiepileptics as Potential Aids to Smoking Cessation
• Antiepileptic Drugs in Obesity, Psychotropic-Associated Weight Gain, and Eating Disorders
• Antiepileptic Drugs in the Treatment of Impulsivity and Aggression and Impulse Control and Cluster B Personality Disorders
• Antiepileptic Drugs and Borderline Personality Disorder
• Antiepileptics in the Treatment of Sleep Disorders
• Use of Antiepileptics in Fibromyalgia

Section III: Potential Psychotropic Mechanisms of Action of AEDs

• Psychotrophic Mechanisms of Action of Antiepileptic Drugs in Mood Disorder

• Susan L. McElroy, University of Cincinnati, Cincinnati, Ohio, USA
  Susan L. Mcelory is Chief Research Officer, Lindner Center of HOPE, Mason, Ohio, USA and professor of psychiatry and neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. Dr. McElroy received her M.D. from Cornell University Medical College, New York, New York, USA. She has been in the list of “The Best Doctors in America” since 1994 and has won the Gerald L. Klerman Young Investigator Award from the National Depressive and Manic Depressive Association.

  Dr. McElroy’s main areas of study include the phenomenology and treatment of bipolar disorder, impulse control disorders, and eating disorders. The relationship among these disorders and their relationship to obesity is also an important area of Dr. McElroy’s research. Dr. McElroy serves on the editorial boards of 3 journals, has published more than 350 scientific papers, and is the editor of four scientific books. She is among the top 10 most cited scientists in the world published in the fields of psychiatry and psychology over the past decade.

• Paul E. Keck, Jr., University of Cincinnati, Cincinnati, Ohio, USA
  Paul E. Keck, Jr.,is President and CEO, Lindner Center of HOPE, Mason, Ohio, USA and professor of psychiatry, neuroscience, and pharmacology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. Dr. Keck achieved his M.D. from Mount Sinai School of Medicine, New York, New York, USA. Dr. Keck’s research concentrates on psychopharmacology and on the phenomenology and treatment of mood and psychotic disorders.

  Throughout his career, Dr. Keck has received numerous awards, including the Gerald L. Klerman Senior Investigator Award from the Depression and Bipolar Disorder Support Alliance (DBSA). He is the author of over 500 scientific papers and among the top 10 most cited scientists in the world published in the fields of psychiatry and psychology over the past decade. Dr. Keck is the editor or author of six scientific books and serves on the editorial boards of seven journals. He also serves on the American Psychiatric Association’s Workgroup to Develop Practice Guidelines for Treatment of Patients with Bipolar Disorders.

• Robert M. Post, National Institute of Mental Health, Bethesda, Maryland, USA
  Robert M. Post heads the Bipolar Collaborative Network and is in private practice in Bethesda, Maryland, USA. Dr. Post received his M.D. from the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. Dr. Post’s research primarily focuses on gaining a better understanding of and treating patients with refractory unipolar and bipolar illness. Dr. Post’s research group has won major research awards from the Society of Biological Psychiatry, APA, ACNP, Anna Monika Foundation, NARSAD, and NDMDA. Dr. Post serves on the editorial boards of more than ten journals and has published more than 900 scientific manuscripts.